Tower Research Capital LLC (Trc) Tiziana Life Sciences LTD Transaction History

Tower Research Capital LLC (Trc)

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.65 - $1.29 $4,009 - $7,956	6,168 Added 52.83%	17,844 $12,000
Q1 2023 May 09, 2023	SELL	$0.51 - $1.1 $2,271 - $4,899	-4,454 Reduced 27.61%	11,676 $13,000
Q4 2022 Feb 10, 2023	BUY	$0.56 - $0.69 $426 - $525	761 Added 4.95%	16,130 $10,000
Q3 2022 Nov 10, 2022	BUY	$0.55 - $0.83 $5,175 - $7,810	9,410 Added 157.91%	15,369 $12,000
Q2 2022 Aug 15, 2022	BUY	$0.66 - $1.06 $2,115 - $3,398	3,206 Added 116.45%	5,959 $4,000

Q1 2022 May 12, 2022	SELL	$0.62 - $1.25 $3,047 - $6,145	-4,916 Reduced 64.1%	2,753 $3,000
Q4 2021 Feb 14, 2022	BUY	$0.89 - $1.66 $6,825 - $12,730	7,669 New	7,669 $7,000

816K

Ticker TLSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,273,000
Market Cap $88M
Description
Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.